Levobunolol | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Levobunolol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 5 USDMF, 1 JDMF, 1 EU WC, 2 NDC API, 2 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

17 FDF Dossiers, 10 FDA Orange Book, 3 Europe, 1 Canada, 2 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - 0.5%, SOLUTION/DROPS;OPHTHALMIC - 0.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

6 Actylis, 1 BASF, 5 Corel Pharma Chem, 2 Finar, 1 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 3 Kerry, 1 Novo Excipients

EXCIPIENTS BY APPLICATIONS

12 Coating Systems & Additives, 6 Parenteral, 4 Controlled & Modified Release, 2 Solubilizers, 2 Topical, 1 API Stability Enhancers, 1 Fillers, Diluents & Binders, 1 Disintegrants & Superdisintegrants

GLOBAL SALES INFORMATION

5 Regulatory FDF Prices

5 Regulatory FDF Prices

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 USP, 2 Others

$ Xls

Filters

Filters

FILTER :

filter Catalog Number Reset all filters

1 All

01 11359801

filter Description Reset all filters

filter CAS Number Reset all filters

Product Main Page

01

USP

Cancer Research

Not Confirmed

Contact us
to update this info